Sandra Morel

3.4k total citations · 1 hit paper
17 papers, 2.5k citations indexed

About

Sandra Morel is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Sandra Morel has authored 17 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Sandra Morel's work include Immunotherapy and Immune Responses (14 papers), Ubiquitin and proteasome pathways (7 papers) and vaccines and immunoinformatics approaches (5 papers). Sandra Morel is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Ubiquitin and proteasome pathways (7 papers) and vaccines and immunoinformatics approaches (5 papers). Sandra Morel collaborates with scholars based in Belgium, Switzerland and France. Sandra Morel's co-authors include Benoı̂t J. Van den Eynde, Arnaud M. Didierlaurent, Thierry Boon, Harald Carlsen, Nathalie Garçon, Marcelle Van Mechelen, Jacques Chapiro, Patricia Bourguignon, Frédéric Lévy and Odile Burlet‐Schiltz and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Sandra Morel

17 papers receiving 2.5k citations

Hit Papers

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant S... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Morel Belgium 16 1.8k 1.2k 554 512 298 17 2.5k
Fabienne Anjuère France 30 1.9k 1.1× 769 0.6× 356 0.6× 419 0.8× 207 0.7× 63 3.0k
Nicole A. Kukutsch Netherlands 13 3.0k 1.7× 945 0.8× 377 0.7× 650 1.3× 200 0.7× 33 3.9k
Natalie A. Borg Australia 28 2.0k 1.2× 783 0.6× 540 1.0× 445 0.9× 372 1.2× 47 3.2k
Masahiko Sugita Japan 37 3.7k 2.1× 612 0.5× 664 1.2× 472 0.9× 387 1.3× 101 4.7k
Sara Brett United Kingdom 27 1.9k 1.1× 501 0.4× 699 1.3× 476 0.9× 529 1.8× 65 2.9k
Andrew W. Heath United Kingdom 24 2.0k 1.1× 502 0.4× 366 0.7× 276 0.5× 192 0.6× 70 2.7k
Flora Castellino Italy 28 2.6k 1.5× 1.0k 0.8× 1.2k 2.2× 397 0.8× 532 1.8× 42 3.8k
Pradyot Dash United States 23 2.0k 1.1× 1.1k 0.9× 776 1.4× 739 1.4× 353 1.2× 35 3.1k
Michael F. Princiotta United States 19 1.6k 0.9× 1.2k 1.0× 456 0.8× 400 0.8× 236 0.8× 34 2.7k
Florian Winau Germany 24 1.5k 0.8× 669 0.5× 738 1.3× 226 0.4× 620 2.1× 29 2.6k

Countries citing papers authored by Sandra Morel

Since Specialization
Citations

This map shows the geographic impact of Sandra Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Morel more than expected).

Fields of papers citing papers by Sandra Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Morel. The network helps show where Sandra Morel may publish in the future.

Co-authorship network of co-authors of Sandra Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Morel. A scholar is included among the top collaborators of Sandra Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Morel. Sandra Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Collignon, Catherine, Vanesa Bol, Aurélie Chalon, et al.. (2020). Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys. Frontiers in Immunology. 11. 579872–579872. 20 indexed citations
2.
Didierlaurent, Arnaud M., Catherine Collignon, Patricia Bourguignon, et al.. (2014). Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells. The Journal of Immunology. 193(4). 1920–1930. 193 indexed citations
3.
Garçon, Nathalie, Sandra Morel, Arnaud M. Didierlaurent, et al.. (2011). Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach. BioDrugs. 25(4). 217–226. 90 indexed citations
4.
Morel, Sandra, et al.. (2011). Induction of Bordetella pertussis-specific immune memory by DTPa vaccines. Vaccine. 29(18). 3449–3455. 10 indexed citations
5.
Morel, Sandra, Arnaud M. Didierlaurent, Patricia Bourguignon, et al.. (2011). Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. Vaccine. 29(13). 2461–2473. 360 indexed citations
6.
Parmentier, Nicolas, Vincent Stroobant, Didier Colau, et al.. (2010). Production of an antigenic peptide by insulin-degrading enzyme. Nature Immunology. 11(5). 449–454. 53 indexed citations
7.
Didierlaurent, Arnaud M., Sandra Morel, Sandra L. Giannini, et al.. (2009). AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity. The Journal of Immunology. 183(10). 6186–6197. 578 indexed citations breakdown →
8.
Chapiro, Jacques, Stéphane Claverol, Fanny Piette, et al.. (2006). Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation. The Journal of Immunology. 176(2). 1053–1061. 125 indexed citations
9.
Chapatte, Laurence, Maha Ayyoub, Sandra Morel, et al.. (2006). Processing of Tumor-Associated Antigen by the Proteasomes of Dendritic Cells ControlsIn vivoT-Cell Responses. Cancer Research. 66(10). 5461–5468. 57 indexed citations
10.
Vigneron, Nathalie, Vincent Stroobant, Jacques Chapiro, et al.. (2004). An Antigenic Peptide Produced by Peptide Splicing in the Proteasome. Science. 304(5670). 587–590. 262 indexed citations
11.
Ma, Wenbin, Nathalie Vigneron, Sandra Morel, et al.. (2004). Two new tumor‐specific antigenic peptides encoded by gene MAGE‐C2 and presented to cytolytic T lymphocytes by HLA‐A2. International Journal of Cancer. 109(5). 698–702. 49 indexed citations
12.
Lévy, Frédéric, Lena Burri, Sandra Morel, et al.. (2002). The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases. The Journal of Immunology. 169(8). 4161–4171. 67 indexed citations
13.
Schultz, Erwin, Jacques Chapiro, Christophe Lurquin, et al.. (2002). The Production of a New MAGE-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40 Requires the Immunoproteasome. The Journal of Experimental Medicine. 195(4). 391–399. 99 indexed citations
14.
Vigneron, Nathalie, Annie Ooms, Sandra Morel, Gérard Degiovanni, & Benoı̂t J. Van den Eynde. (2002). Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma.. PubMed. 2. 9–9. 18 indexed citations
15.
Eynde, Benoı̂t J. Van den & Sandra Morel. (2001). Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Current Opinion in Immunology. 13(2). 147–153. 161 indexed citations
16.
Morel, Sandra, Frédéric Lévy, Odile Burlet‐Schiltz, et al.. (2000). Processing of Some Antigens by the Standard Proteasome but Not by the Immunoproteasome Results in Poor Presentation by Dendritic Cells. Immunity. 12(1). 107–117. 349 indexed citations
17.
Morel, Sandra, et al.. (1999). A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes. International Journal of Cancer. 83(6). 755–759. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026